Royal Bank Of Canada reiterated their sector perform rating on shares of Concordia Healthcare Corp (TSE:CXR) (NASDAQ:CXRX) in a research report sent to investors on Monday.

Other analysts have also recently issued reports about the stock. Goldman Sachs Group Inc. lowered their price objective on shares of Concordia Healthcare Corp from C$34.00 to C$17.00 in a research note on Monday, August 15th. Bloom Burton reissued a hold rating on shares of Concordia Healthcare Corp in a research note on Wednesday, October 26th. TD Securities boosted their price objective on shares of Concordia Healthcare Corp from C$7.00 to C$14.00 and gave the company a hold rating in a research note on Monday, September 19th. Finally, CIBC cut shares of Concordia Healthcare Corp from a sector perform rating to an underperform rating in a research note on Monday, August 15th. Two equities research analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. Concordia Healthcare Corp has a consensus rating of Hold and a consensus target price of C$26.13.

Analyst Recommendations for Concordia Healthcare Corp (TSE:CXR)

Concordia Healthcare Corp (TSE:CXR) opened at 4.41 on Monday. The stock’s market cap is $224.98 million. Concordia Healthcare Corp has a 12-month low of $2.27 and a 12-month high of $28.35. The company has a 50-day moving average price of $4.78 and a 200 day moving average price of $18.20.

Concordia Healthcare Corp Company Profile

Receive News & Stock Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related stocks with our FREE daily email newsletter.